Comera SPAC Presentation Deck

Biologics Market is Massive and Growing Rapidly Global biologics market was $286B in 2020 and expected to grow to $422B in 20251 7 of the top 10 global medicines are biologics² Products across all major therapeutic indications Biologics are at the vanguard of cutting-edge biomedical technology and are driving the next generation of treatments for patients 1. Rituxan® Rituximab X Outnumbering-Small-Molecule-Drugs.html Multiple $Billion Products Herceptin® trastuzumab SOLIRISⓇ (eculizumab) Source: https://www.bccresearch.com/market-research/biotechnology/biologic-therapeutic-drugs-technologies-markets-report.html: Based on revenues generated by each product as disclosed in the annual reports for such companies that produce each of these products. 2. Source: https://www.globenewswire.com/news-release/2019/01/11/1690388/0/en/Global-Biologics-Outsourcing-Market-2018-2027-In-2017-7-out-of-10-Blockbuster-Drugs-were-Biologics- (.<) Comera LIFE SCIENCES RemicadeⓇ INFLIXIMAB AVASTIN® bevacizumab KEYTRUDA (pembrolizumab) 10

View entire presentation